Ken Griffin Neuro Metrix, Inc. Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.61 - $0.98 $17,154 - $27,559	28,122 New	28,122 $20,000
Q3 2022 Nov 14, 2022	BUY	$2.97 - $23.6 $31,636 - $251,387	10,652 Added 44.3%	34,699 $97,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $5.5 $67,572 - $132,258	24,047 New	24,047 $88,000
Q3 2021 Nov 15, 2021	SELL	$3.23 - $24.73 $92,982 - $711,902	-28,787 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.72 - $3.8 $41,640 - $58,174	15,309 Added 113.59%	28,787 $98,000
Q1 2021 May 17, 2021	BUY	$3.01 - $5.35 $258 - $460	86 Added 0.64%	13,478 $46,000
Q4 2020 Feb 16, 2021	BUY	$1.5 - $3.64 $20,088 - $48,746	13,392 New	13,392 $42,000

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $31.6M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.